La gestión sanitaria en la atención a la población indígena y afroperuana en la pandemia por la COVID-19

Objetivo : Conocer las barreras en la gestión de los establecimientos de salud que atienden a población indígena y afrodescendiente del Perú. Material y métodos : Se diseñó una encuesta virtual en gestión sanitaria al personal del primer nivel de atención de 89 establecimientos de salud (EESS) de 27 provincias, durante los meses de octubre y noviembre del 2021. Resultados : En el 73 % de EESS, el personal refiere no conocer el plan contra la tercera ola pandémica, 14,8% de EESS el personal refiere no está capacitado en manejo de la COVID-19, en el 22,7% de EESS se reunieron para coordinar cómo enfrentar la tercera ola pandémica, en el 83% de EESS el personal refiere no contar con presupuesto para su plan contra la COVID-19. Conclusiones : Hay barreras en la visión, gestión y presupuesto en EESS que atienden poblaciones indígenas y afroperuano, lo que afectaría la ejecución eficaz de estrategias para el control de la pandemia por la COVID-19.

Objective : To determine the barriers in the management of health facilities that serve the indigenous and Afro-descendant population in Peru. Material and methods : A virtual survey on health management was designed for first level health care personnel in 89 health facilities (EESS) in 27 provinces during October and November 2021. Results : In 73% of the EESS, the personnel reported not knowing the plan against the third pandemic wave, 14.8% of the EESS reported not being trained in the management of COVID-19, in 22.7% of the EESS they met to coordinate how to face the third pandemic wave, in 83% of the EESS the personnel reported not having a budget for their plan against COVID-19. Conclusions : There are barriers in the vision, management and budget in EESS that serve indigenous and Afro-Peruvian populations, which would affect the effective execution of strategies for the control of the pandemic by COVID-19.

Treponema peruense sp. nov., a commensal spirochaete isolated from human faeces.

A Gram-stain-negative, obligatory anaerobic spirochaete (RCC2812T) was isolated from a faecal sample obtained from an individual residing in a remote Amazonian community in Peru. The bacterium showed highest 16S rRNA gene sequence similarity to the pig intestinal spirochete Treponema succinifaciens (89.48 %). Average nucleotide identity values between strain RCC2812T and all available Treponema genomes from validated type strains were all <73 %, thus clearly lower than the species delineation threshold. The DNA G+C content of RCC2812T was 41.24 mol%. Phenotypic characterization using the API-ZYM and API 20A systems confirmed the divergent position of this bacterium within the genus Treponema. Strain RCC2812T could be differentiated from the phylogenetically most closely related T. succinifaciens by the presence of alkaline phosphatase and α -glucosidase activities. Unlike T. succinifaciens, strain RCC2812T grew equally well with or without serum. Strain RCC2812T is the first commensal Treponema isolated from the human faecal microbiota of remote populations, and based on the collected data represents a novel Treponema species for which the name Treponema peruense sp. nov. is proposed. The type strain is RCC2812T (=LMG 31794T=CIP 111910T).

The genetic structure and adaptation of Andean highlanders and Amazonians are influenced by the interplay between geography and culture.

Western South America was one of the worldwide cradles of civilization. The well-known Inca Empire was the tip of the iceberg of an evolutionary process that started 11,000 to 14,000 years ago. Genetic data from 18 Peruvian populations reveal the following: 1) The between-population homogenization of the central southern Andes and its differentiation with respect to Amazonian populations of similar latitudes do not extend northward. Instead, longitudinal gene flow between the northern coast of Peru, Andes, and Amazonia accompanied cultural and socioeconomic interactions revealed by archeology. This pattern recapitulates the environmental and cultural differentiation between the fertile north, where altitudes are lower, and the arid south, where the Andes are higher, acting as a genetic barrier between the sharply different environments of the Andes and Amazonia. 2) The genetic homogenization between the populations of the arid Andes is not only due to migrations during the Inca Empire or the subsequent colonial period. It started at least during the earlier expansion of the Wari Empire (600 to 1,000 years before present). 3) This demographic history allowed for cases of positive natural selection in the high and arid Andes vs. the low Amazon tropical forest: in the Andes, a putative enhancer in HAND2-AS1 (heart and neural crest derivatives expressed 2 antisense RNA1, a noncoding gene related to cardiovascular function) and rs269868-C/Ser1067 in DUOX2 (dual oxidase 2, related to thyroid function and innate immunity) genes and, in the Amazon, the gene encoding for the CD45 protein, essential for antigen recognition by T and B lymphocytes in viral-host interaction.

Prevalence of retrovirus, hepatitis B and D infection in the Matsés ethnic group in Loreto, Peru. / Prevalencia de infección por los virus de la hepatitis B, D y por retrovirus en la etnia Matsés (Loreto, Perú).

Observational, cross-sectional, populational study to determine the prevalence of infection by hepatitis B virus (HBV), hepatitis D virus (HDV), human immunodeficiency virus (HIV) and human T-lymphotropic virus type 1 and 2 (HTLV-1/2) in the Matsés ethnic group, after immunization against HBV. ELISA and qPCR tests were used in 963 residents. The prevalence of HBsAg, Anti-HBc and Anti-HBs was 3.32%, 36.03% and 58.67% respectively. In 3.1% of the population the viral load was greater than 2000 IU/mL. In children under 10 years, the prevalence of HBsAg and anti-HBc was 0.0% and 2.6%, respectively, while protective antibodies were found in 94.4%. The prevalence of HIV and HTLV-1/2 infection was 1.5% and 0.6%, respectively. It is therefore concluded that there are low rates of HBV and HDV infection in the Matsés child population. Likewise, the presence of HIV and HTLV-1/2 infection is confirmed.

Para determinar la prevalencia de infección por los virus de la hepatitis B y D (VHB y VHD, respectivamente), VIH y HTLV-1/2 en la etnia matsés, después de la inmunización contra el VHB se realizó un estudio transversal y poblacional, utilizando pruebas de ELISA y qPCR en 963 pobladores. Las prevalencias de HBsAg, anti-HBc y anti-HBs fueron 3,3%, 36,0% y 58,7%, respectivamente. En el 3,1% de la población la carga viral fue mayor a 2000 UI/mL. En menores de 10 años, la prevalencia de HBsAg y anti-HBc fue 0,0% y 2,6%, respectivamente, mientras que en el 94,4% se encontraron anticuerpos protectores. La prevalencia de infección por el VIH y el HTLV-1/2 fue 1,5% y 0,6%, respectivamente. Se concluye que existen tasas bajas de infección por el VHB y el VHD en la población infantil de la etnia matsés. Asimismo, se confirma la presencia de infección por el VIH y el HTLV-1/2.

Decrease in the prevalence of hepatitis B and D virus infections in an endemic area in Peru 23 years after the introduction of the first pilot vaccination program against hepatitis B.

In 1991, Peru launched the first vaccination program against hepatitis B in children aged under 5 years in the hyperendemic [hepatitis B virus (HBV) and hepatitis D virus (HDV)] province of Abancay. We conducted a cross-sectional study to determine the prevalence of HBV and HDV infections, 23 years after the launch of the vaccination program, as well as the post-vaccine response against hepatitis B in terms of prevalence of hepatitis B surface antibody (anti-HBs ≥10 mUI/ml). Among 3165 participants aged from 0 to 94 years, the prevalence rates of hepatitis B surface antigen (HBsAg), and hepatitis B core antibody (total anti-HBc) were 1.2% [95% confidence interval (CI) 0.85-1.64%], and 41.67% (95% CI 39.95-43.41%), respectively. The prevalence rate of anti-HBs at protective levels (≥10 mUI/ml) in individuals who HBsAg and anti-HBc negative was 66.36% (95% CI 64.15-68.51%). The prevalence rate of HBsAg in children aged <15 years was nil, and among adult HBsAg carriers, the prevalence of hepatitis D antibody (anti-HDV) was 5.26% (2/38; 95% CI 0.64-17.74). These findings showed that HBV prevalence has changed from high to low endemicity, 23 years following implementation of the vaccination program against hepatitis B, and HDV infection was not detected in those aged <30 years.

Seroepidemiology of hepatitis A, B, C, D and E virus infections in the general population of Peru: A cross-sectional study.

BACKGROUND: Viral hepatitis (hepatitis A, B, C, D and E) remains a public health problem in Peru, with a high disease burden. There are limited data on the prevalence of viral hepatitis at a national level, and none reported for over two decades. In this study, the prevalence rates of hepatitis A (HAV), B (HBV), C (HCV), D (HDV) and E virus (HEV) infections in the Peruvian population were determined to provide updated baseline data that would help guide the development of strategies aimed at reducing the transmission of viral hepatitis in Peru. METHODS: We conducted a cross-sectional, population-based study in the 25 regions of Peru. The study included participants of both sexes, aged 15-69 years, who had lived for >6 months in a specific region of Peru. Serum samples were analyzed by ELISA for anti-HAV (IgG), anti-HBs ≥10 mUI/ml, anti-HCV, anti-HDV and anti-HEV (IgG) antibodies, and by chemiluminescence for the HBV surface antigen (HBsAg) and antibodies against the core HBV antigen (anti-HBc IgM and IgG). RESULTS: In a total of 5183 study participants, the prevalence rates of anti-HAV (IgG), HBsAg, total anti-HBc IgG, anti-HBs ≥10 mUI/ml, anti-HCV and anti-HEV (IgG) were 98.4% [95% confidence interval (CI) 98.0-98.7), 0.4% (95% CI 0.21-0.55), 10.1% (95% CI 9.4-11.0), 60% (95% CI 58.5-61.2), 0.1% (95% CI 0.02-0.25), and 14% (95% CI 13.1-15.0%), respectively. The prevalence of anti-HDV among HBsAg carriers was 15% (3/20). CONCLUSIONS: The prevalence of HAV and HEV in the population aged 15-69 years in Peru is high, while the prevalence of HBV and HDV has changed from intermediate to low endemicity level and the prevalence of HCV is low. These findings would prove useful in the development of new strategies aimed at reducing the transmission of viral hepatitis in Peru, with a view to ultimately eliminating these infections in the future.

[Reduction of HBV and HDV infection in two indigenousmpeoples of Peruvian Amazon after the vaccination against hepatitis B]. / Reducción en la infección por VHB y VHD en dos poblaciones indígenas de la Amazonia peruana después de la vacunación contra la hepatitis B.

OBJECTIVE: To determine the outcome of the vaccination against hepatitis, we determined the prevalence of hepatitis B virus (HBV) and hepatitis D virus (HDV) infections, eight years after introduction of the vaccination. MATERIALS AND METHODS: A cross-sectional study was performed in 2 944 participants of 67 Kandozi and Chapra indigenous peoples in April 2010. Serological screening for hepatitis B surface antigen (HBsAg), antibody anti-HBc IgM and IgG, antibody anti-HBs and anti-HDV were determined by ELISA tests. RESULTS: The prevalence rates of HBsAg, anti-HBc total, anti- HBs ≥10 mlUI/ml and anti-HDV were 2.3, 39.13, 50.95 and 2.11%, respectively. The prevalence rate of HBsAg in children <11 years was 0%. Among carriers of HBsAg, the prevalence rates of HDV and acute HBV infections were 2.11% (all were >14 years) and 11.94%, respectively. HBsAg and anti-HBc total were associated with individuals ≥10 years (p<0.001). CONCLUSIONS: These findings show the elimination of HBVmcarriers in children <11 years, eight years following introduction of the vaccination against HBV.

OBJETIVO: Conocer el resultado de la vacunación contra la hepatitis B en las comunidades hiperendémicas Kandozi y Chapra de la Amazonia Peruana a partir de la prevalencia de infecciones por los virus de la hepatitis B (VHB) y Delta (VHD), ocho años después de iniciada la vacunación. MATERIAL Y MÉTODOS: Se realizó un estudio transversal en 2 944 pobladores de 67 comunidades indígenas Kandozi y Chapra en abril de 2010. El tamizaje serológico para el antígeno de superficie del VHB (HBsAg), anticuerpos anti-HBc IgM e IgG, anticuerpos anti-HBs y anti-VHD se determinaron mediante pruebas de ELISA. RESULTADOS: Las tasas de prevalencia del HBsAg, anti-HBc IgG, anti-HBs ≥10 mlUI/ml y anti-VHD fueron 2.3, 39.13, 50.95 y 2.11%, respectivamente. La prevalencia del HBsAg en niños <11 años fue cero. Entre los portadores del HBsAg, las tasas de prevalencia de sobreinfeccion por el VHD e infección aguda por el VHB fueron 2.11% (todos fueron >14 años) y 11.94%, respectivamente. CONCLUSIONES: Estos hallazgos muestran la eliminación de portadores de VHB en niños <11 años, ocho años después de iniciada la vacunación contra el VHB.

Prevalencia de infección por los virus de la hepatitis B, D y por retrovirus en la etnia Matsés (Loreto, Perú) / Prevalence of retrovirus, hepatitis B and D infection in the Matsés ethnic group in Loreto, Peru

RESUMEN Para determinar la prevalencia de infección por los virus de la hepatitis B y D (VHB y VHD, respectivamente), VIH y HTLV-1/2 en la etnia matsés, después de la inmunización contra el VHB se realizó un estudio transversal y poblacional, utilizando pruebas de ELISA y qPCR en 963 pobladores. Las prevalencias de HBsAg, anti-HBc y anti-HBs fueron 3,3%, 36,0% y 58,7%, respectivamente. En el 3,1% de la población la carga viral fue mayor a 2000 UI/mL. En menores de 10 años, la prevalencia de HBsAg y anti-HBc fue 0,0% y 2,6%, respectivamente, mientras que en el 94,4% se encontraron anticuerpos protectores. La prevalencia de infección por el VIH y el HTLV-1/2 fue 1,5% y 0,6%, respectivamente. Se concluye que existen tasas bajas de infección por el VHB y el VHD en la población infantil de la etnia matsés. Asimismo, se confirma la presencia de infección por el VIH y el HTLV-1/2.

ABSTRACT Observational, cross-sectional, populational study to determine the prevalence of infection by hepatitis B virus (HBV), hepatitis D virus (HDV), human immunodeficiency virus (HIV) and human T-lymphotropic virus type 1 and 2 (HTLV-1/2) in the Matsés ethnic group, after immunization against HBV. ELISA and qPCR tests were used in 963 residents. The prevalence of HBsAg, Anti-HBc and Anti-HBs was 3.32%, 36.03% and 58.67% respectively. In 3.1% of the population the viral load was greater than 2000 IU/mL. In children under 10 years, the prevalence of HBsAg and anti-HBc was 0.0% and 2.6%, respectively, while protective antibodies were found in 94.4%. The prevalence of HIV and HTLV-1/2 infection was 1.5% and 0.6%, respectively. It is therefore concluded that there are low rates of HBV and HDV infection in the Matsés child population. Likewise, the presence of HIV and HTLV-1/2 infection is confirmed.

Reducción en la infección por VHB y VHD en dos poblaciones indígenas de la Amazonia peruana después de la vacunación contra la hepatitis B / Reduction of HBV and HDV infection in two indigenous peoples of Peruvian Amazon after the vaccination against hepatitis B

Resumen: Objetivo: Conocer el resultado de la vacunación contra la hepatitis B en las comunidades hiperendémicas Kandozi y Chapra de la Amazonia Peruana a partir de la prevalencia de infecciones por los virus de la hepatitis B (VHB) y Delta (VHD), ocho años después de iniciada la vacunación. Material y métodos: Se realizó un estudio transversal en 2 944 pobladores de 67 comunidades indígenas Kandozi y Chapra en abril de 2010. El tamizaje serológico para el antígeno de superficie del VHB (HBsAg), anticuerpos anti-HBc IgM e IgG, anticuerpos anti-HBs y anti-VHD se determinaron mediante pruebas de ELISA. Resultados: Las tasas de prevalencia del HBsAg, anti-HBc IgG, anti-HBs ≥10 mlUI/ml y anti-VHD fueron 2.3, 39.13, 50.95 y 2.11%, respectivamente. La prevalencia del HBsAg en niños <11 años fue cero. Entre los portadores del HBsAg, las tasas de prevalencia de sobreinfeccion por el VHD e infección aguda por el VHB fueron 2.11% (todos fueron >14 años) y 11.94%, respectivamente. Conclusiones: Estos hallazgos muestran la eliminación de portadores de VHB en niños <11 años, ocho años después de iniciada la vacunación contra el VHB.

Abstract: Objective: To determine the outcome of the vaccination against hepatitis, we determined the prevalence of hepatitis B virus (HBV) and hepatitis D virus (HDV) infections, eight years after introduction of the vaccination. Materials and methods: A cross-sectional study was performed in 2 944 participants of 67 Kandozi and Chapra indigenous peoples in April 2010. Serological screening for hepatitis B surface antigen (HBsAg), antibody anti-HBc IgM and IgG, antibody anti-HBs and anti-HDV were determined by ELISA tests. Results: The prevalence rates of HBsAg, anti-HBc total, anti-HBs ≥10 mlUI/ml and anti-HDV were 2.3, 39.13, 50.95 and 2.11%, respectively. The prevalence rate of HBsAg in children <11 years was 0%. Among carriers of HBsAg, the prevalence rates of HDV and acute HBV infections were 2.11% (all were >14 years) and 11.94%, respectively. HBsAg and anti-HBc total were associated with individuals ≥10 years (p<0.001). Conclusions: These findings show the elimination of HBV carriers in children <11 years, eight years following introduction of the vaccination against HBV.

Evolutionary genomic dynamics of Peruvians before, during, and after the Inca Empire.

Native Americans from the Amazon, Andes, and coastal geographic regions of South America have a rich cultural heritage but are genetically understudied, therefore leading to gaps in our knowledge of their genomic architecture and demographic history. In this study, we sequence 150 genomes to high coverage combined with an additional 130 genotype array samples from Native American and mestizo populations in Peru. The majority of our samples possess greater than 90% Native American ancestry, which makes this the most extensive Native American sequencing project to date. Demographic modeling reveals that the peopling of Peru began ∼12,000 y ago, consistent with the hypothesis of the rapid peopling of the Americas and Peruvian archeological data. We find that the Native American populations possess distinct ancestral divisions, whereas the mestizo groups were admixtures of multiple Native American communities that occurred before and during the Inca Empire and Spanish rule. In addition, the mestizo communities also show Spanish introgression largely following Peruvian Independence, nearly 300 y after Spain conquered Peru. Further, we estimate migration events between Peruvian populations from all three geographic regions with the majority of between-region migration moving from the high Andes to the low-altitude Amazon and coast. As such, we present a detailed model of the evolutionary dynamics which impacted the genomes of modern-day Peruvians and a Native American ancestry dataset that will serve as a beneficial resource to addressing the underrepresentation of Native American ancestry in sequencing studies.

[Tuberculosis in the indigenous population of Peru 2008]. / Tuberculosis en la población indígena del Perú 2008.

OBJECTIVE: To identify the indigenous inhabitants affected by tuberculosis (TB) in Peru during the year 2008. MATERIAL AND METHODS: Descriptive observational study, performed from August to December 2009, including all indigenous patients affected by tuberculosis that were including in the Control Program during the year 2008 in the 25 regions of Peru. RESULTS: We identified 702 indigenous patients with tuberculosis. The ethnical groups that have most patients were the Quechua group (417/702; 59.4%) and the Amazonic indigenous (201/702, 28.6%). Out of the Amazonic, more than 60% belonged to the Ashaninka (Campas), Shipibo and Matsiguenga groups. In third place, we found the Aymara natives, who had 84/702 (11.97%) of cases of tuberculosis. It is important to mention that the distribution of the cases of multidrugresistant tuberculosis (MDR TB) involves five departments (nine cases of MDR TB), being the greater number of cases of MDR TB in patients previously treated (6/9), and only 3 cases were primary MDR TB, belonging to the quechua group. CONCLUSIONS: High incidence rates of tuberculosis in indigenous population have been found, which raises the need of further research in order to guarantee the correct gathering of information in ethnic groups in order to have more and better evidence about the situation of tuberculosis in the indigenous population of Peru.

Tuberculosis en la población indígena del Perú 2008 / Tuberculosis in the indigenous population of Peru 2008

Objetivos. Identificar a los pobladores indígenas afectados por tuberculosis (TB) en el Perú durante el año 2008. Materiales y métodos. Estudio observacional, descriptivo, realizado de agosto a diciembre de 2009, que incluyó a los pacientes indígenas afectados por tuberculosis que ingresaron al programa durante el año 2008, de las 25 regiones delPerú; los cuales se presentan en tablas y gráficos elaborados en SPSS 16.0 y Excell 2007. Resultados. Se identificó a 702 indígenas con tuberculosis. El grupo étnico que presenta la mayor cantidad de pacientes con TB son los quechuas(417/702; 59,4 por ciento), los indígenas amazónicos (201/702; 28,6 por ciento) de los cuales los grupos étnicos que presenta más del 60 por ciento de indígenas con TB, son los Ashaninka (Campas), Shipibo y Matsiguenga. En tercer lugar se encuentran los indígenas aymaras quienes presentaron (84/702; 11,97 por ciento de todos los pacientes diagnosticados con TB). Es importante mencionar que la distribución de los casos de tuberculosis multidrogoresistente involucra a cinco departamentos (nueve casos con TB MDR), siendo mayor el número de casos de TB MDR antes tratado 6/9, encontrándose sólo tres casos de TB MDR nuevos, pertenecientes al grupo indígena quechua. Conclusiones. Se han reportado altas tasas de incidenciaen población indígena, lo que hace necesario investigaciones más profundas que garanticen la adecuada recolección de información por grupos étnicos a fin de contar con una evidencia de mayor jerarquía acerca de la situación de la tuberculosis en población indígena del Perú.

Objective. To identify the indigenous inhabitants affected by tuberculosis (TB) in Peru during the year 2008. Material and methods. Descriptive observational study, performed from August to December 2009, including all indigenous patients affected by tuberculosis that were including in the Control Program during the year 2008 in the 25 regions of Peru. Results. We identified 702 indigenous patients with tuberculosis. The ethnical groups that have most patients were the Quechua group (417/702; 59.4 per cent) and the Amazonic indigenous (201/702, 28.6 per cent). Out of the Amazonic, more than 60 per cent belonged to the Ashaninka (Campas), Shipibo and Matsiguenga groups. In third place, we found the Aymara natives, who had 84/702 (11.97 per cent) of cases of tuberculosis. It is important to mention that the distribution of the cases of multidrugresistant tuberculosis (MDR TB) involves five departments (nine cases of MDR TB), being the greater number of cases of MDR TB in patients previously treated (6/9), and only 3 cases were primary MDR TB, belonging to the quechua group. Conclusions. High incidence rates of tuberculosis in indigenous population have been found, which raises the need offurther research in order to guarantee the correct gathering of information in ethnic groups in order to have more and better evidence about the situation of tuberculosis in the indigenous population of Peru.

Tuberculosis en poblaciones indígenas del Perú: Los Aimaras del Perú, 2000-2005 / Tuberculosis in indigenous populations in Peru: The Aimara of Peru, 2000-2005

Objetivos: Describir la situación de la tuberculosis en distritos aimaras del Perú, en términos de incidencia y mortalidad, y la relación con la altura y otros indicadores sociales. Material y métodos: Se realizó un estudio ecológico tomando como unidad de análisis a todos los distritos aimaras del país, comparándolos con los no aimaras, en altura, población con alta dependencia económica, población con al menos una necesidad básica insatisfecha (NBI), y hacinamiento.Se realizó un análisis de regresión lineal, que fue complementado con investigación cualitativa. Para el análisis cuantitativo se utilizó el programa estadístico SPSS versión 12.0, y Excel. Resultados: En los distritos aimaras estudiados, se identificó una incidencia promedio de tuberculosis pulmonar frotis positivo (TBP FP) de 33.35 por 100 000 habitantes, con un máximo de 399.39 por 100 000 habitantes, se encontró que las variables estudiadas (población con alta carga o dependencia económica, población con al menos una NBI, hacinamiento y altitud) explicaban parcialmente el modelo (R2 = 0.468), mostrando un R = 0.68. Se identificaron los condicionantes culturales como externo, referido a la migración estacional por trabajo a zonas productivas, y como cultural interactuante, referido a la relación entre la cultura que migra y la que acoge, modificando sus estilos de vida como alimentación y en consecuencia la salud. Conclusiones: Se ha observado que la altura no es el único factor que explica el modelo y que los otros factores sociales estudiados, así como el factor cultural, intervienen para explicar la incidencia de tuberculosis en aimaras.

Objectives: To describe the situation of TB in aimara districts from Peru, in terms of incidence and mortality, and the relationship with altitude and other social indicators. Methods: An ecological study, having as a unit of analysis all the aimara districts of the country, compared with non-aimara districts, by altitude, people with high economic dependence, people with at least one unmet basic need, and overcrowding. We performed a regression analysis, which was complemented with qualitative research methods. For the quantitative analysis we use the statistical program SPSS 12.0 and Excel. Results: In the aimara districts studied, we identified an incidence of smear positive pulmonary TB (TBP FB) of 33.35 per 100 000 habitants, with a maximum of 399.39 per 100 000 habitants, it was found that the variables studied (people with high load or economic dependence,people with at least one unmet basic needs, overcrowding and altitude) partially explain the model (R2 = 0.468), showing an R = 0.68. Cultural conditions were identified as external, related to seasonal migration for work in productive areas, and as cultural interactive, referring to the relationship between the culture that migrates and the one that welcomes, changing lifestyles such as food and thus health. Conclusions: We observed that the altitude is not the only factor that explains the model and that the other factors studied, like social and cultural factors, are involved to explain the incidence of tuberculosis in aimara populations.

El chacho (alcanzo, hapiruzqa), Síndrome cultural andino: características y tratamiento tradicional en Ayacucho, Perú / Chacho (Alcanzo, Hapiruzqa), Andean cultural syndrome: frequency, characteristics and traditional treatments in Ayacucho, Peru

Objetivos. Conocer el cuadro clínico, formas de diagnóstico y tratamiento de los pacientes que presentan el síndrome conocido como chacho y cuál es su prevalencia sentida en cinco distritos de Ayacucho. Materiales y métodos. Estudio cuali-cuantitativo, que incluyó dos grupos de participantes, el primero (95) fueron pobladores o familiares de éstos, que alguna vez en su vida presentaron chacho, el segundo grupo (11) constituido por curanderos de cada comunidad. Resultados. El chacho (alcanzo, hapiruzqa en quechua), se considera como una enfermedad de origen mágico, caracterizada por presentar fiebre, malestar general, rechazo a algunos derivados lácteos y carne de chancho; en la mayoría de los pacientes se menciona el antecedente de descanso cercano a un cerro o dormir en el suelo (tierra). El tiempo de duración de la enfermedad fue menor de una semana en promedio y se evidenció que el tratamiento incluye, el consumo de gasolina, creso, kerosene, así como el pagapo (pago a la tierra). El consumo de medicamentos agrava la condición de salud del paciente. La prevalencia sentida varió entre 9,1 a 38,0 casos por mil habitantes y la mortalidad sentida entre 3,8 a 16,8 por diez mil habitantes. Conclusiones. El chacho es un síndrome cultural vigente, que debeser reconocido y abordado por el personal de salud, brindándonos así la oportunidad, de armonizar los conocimientos ancestrales de la medicina tradicional con los biomédicos actuales.

Objectives. Knowing the clinical features, diagnose and treatment for patients with the syndrome mean as chacho and what is its perceived prevalence in five districts of Ayacucho (Peruvian Central Andes). Material and methods. Qualiquantitative study, which included two groups of participants, the first (95) were residents or relatives of those who have ever had in your life chacho, the second group (11) formed by traditional healers of every community. Resultados. Chacho (alcanzo, hapiruzqa in quechua), is regarded as a disease of magical origin, characterized by fever, malaise, rejection of some dairy products and pork, in most patients referred the antecedent of a to rest near hill or sleep on the floor (ground ). The duration of the disease was less than a week on average and it was shown that treatment includes the consumption of gasoline, creso (disinfectant), kerosene, as well as the pagapo (Andean ritual of payment to the ground). The consumption of drugs worsens the health condition of patients. Perceived prevalence ranged between 9.1 to 38.0 cases per thousand people habitants, and perceived mortality from 3.8 to 16.8 per ten thousand habitants. Conclusions. Chacho is a present cutlural syndrome, which must be recognized and addressed by health personnel, thus giving them the opportunity to bring the ancestral knowledge of traditional medicine with the current biomedical.

Trastorno de estrés agudo y episodio depresivo mayor en víctimas de una inundación en Tingo María: prevalencia y efectos de su desplazamiento a un albergue / Acute stress disorder and major depressive desorder in flood victims from Tingo Maria: prevalence ande the effect of relocating

Objetivos. Determinar la prevalencia del trastorno de estrés agudo (TEA) y comorbilidad con episodio depresivo mayor (TEA mas EDM) en víctimas de la inundación de la ciudad Tingo María-Huánuco, 20 días después del evento traumático. Materiales y métodos. Ciento veinte damnificados (personas del albergue) y 110 afectados (personas en sus viviendas) fueron encuestados y comparados. Se aplicó la entrevista clínica estructurada para los trastornos del Eje I del DSM-IV, versión clínica. Las prevalencias de los trastornos estudiados fueron estratificadas por edad, ser mujer, tener una pareja al tiempo de ocurrencia del desastre, estar desempleado cuando ocurrió el desastre, no hablar castellano y tener un nivel de instrucción bajo. Los datos fueron analizados en STATA v.8.0. Resultados. El 64,8% (IC95 % : 58,6 -71,0) de la población estudiada fue diagnosticada con TEA y un 28,3% (IC95 %: 22,4 - 34,1) tuvo TEA+EDM. Los damnificados mostraron prevalencias mayores de TEA, 80%, frente a 48,2% en los afectados (p < 0,001). Para el caso de TEA+EDM las prevalencias fueron 40,0 % y 15,5 %, respectivamente (p < 0,001). Las mujeres tienen mayor riesgo de desarrollar TEA (OR: 4,3; IC 95 < 1,6 menos 11,2) y TEA mas EDM (OR: 8,7; IC 95 % 1,9-40,9) independientemente de los otros factores. Conclusiones. Existe diferencias importantes entre las prevalencias de trastornos mentales de las personas que habitan en un albergue o en su vivienda; siendo mayor en quienes se ven obligados a vivir temporalmente en albergues. Las mujeres son más propensas a sufrir estos trastornos mentales.

Objectives. To determine the prevalence of acute stress disorder (ASD) and comorbidity with major depressive disorder (ASD+MDD) in flood victims from Tingo María, Huánuco (Peruvian central jungle), 20 days after the traumatic event. Material and methods: One hundred and twenty injured (people relocated after disaster) and 110 affected (people living in their own homes) were surveyed and compared. Was applied to structured clinical interview for disorders axis Ifrom DSM-IV, clinical version. The prevalence of the disorders studied were stratified by age, being a woman, having a partner at the time of occurrence of the disaster, unemployed time of the disaster, not to speak Spanish and have low levels of education. The data were analyzed in STATA v.8.0. Results. The 64.8% (95CI: 58.6-71.0) of the study population had ASD and the 28.3% (95CI: 22.4-34-1) had ASD+MMD. The people injured showed higher prevalence of ASD, 80%, compared with 48.2% for those affected (P < 0.001). In the case of ASD+MMD prevalences were 40.0% and 15.5%, respectively (P < 0.001). Women are more likely to develop ASD (OR: 4.3; 95CI: 1.6-11.2) and ASD+DDM (OR: 8.7; 95CI: 1.9-40.9) adjusted of other factors. Conclusions. There are significant differences between the prevalence of mental disorders of the people living in a shelter or in their own homes; being higher in those who are forced to live in temporary shelters. Women are more susceptible to these mental disorders.